AzTrials
AzTrials

Tobacco Use CessationNCT07031024

Tabacco Cessation in Hospital Services

An observational study of Tobacco Use Cessation, run by Centre Hospitalier Universitaire de Nice at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Tobacco poses a health risk, whatever the method of consumption. According to the baro cancer 2021 : Only 23% of smokers say they have discussed smoking with a healthcare professional in the last 12 months. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Tobacco Use Cessation
How many people
400 participants
Where
1 siteFrance
Study dates
1 Jul 2024to 30 Aug 2025
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: Smoking patients attending the Nice Institute of Oral Medicine. Practitioners, interns and 4th, 5th and 6th year students.

Who may be able to join

  • Patients: Female male non gendered.
  • Over 18 years old
  • Whatever their state of healthRegular smoker: According to the Institut national de prévention et d'éducation pour la santé (INPES) and World Health Organization (WHO), a regular smoker is someone who reports smoking at least one cigarette (or equivalent) a day.
  • Whether or not they use any other form of 'drug'.
  • Whatever the reason for their consultation.
  • Signature of no objection form
Show all 12Show fewer
  • Praticiens:- Male , Female non gendered
  • Age 18 years
  • General practitioner at CHU ( Professor - MCU - Assistant - Associate)
  • Specialist at the University Hospital (Professor - MCU - Assistant - Associate)
  • Intern (oral medicine - oral surgery - orthodontics)
  • student (4th, 5th and 6th year)"

Who cannot join

  • Patients: Ex-smoker patients
  • Non-smokers
  • Patients under guardianship
  • Patients with language difficulties
  • Praticiens: - Non-dentistry students
  • Student in dentistry without clinical practice (2nd, 3rd year)

Trial locations and contacts

1 site in 1 country.

France1 site
  • CHU NICE

    Nice, Alpes Maritimes, 06000

Other trials in France

About this study

Official title: Tabacco Cessation: Evaluation of Patient Perceptions and Professional Practices in the Odontology Department of the Nice Institute of Oral Medicine

Tobacco poses a health risk, whatever the method of consumption. According to the baro cancer 2021 : Only 23% of smokers say they have discussed smoking with a healthcare professional in the last 12 months. Studies in France on the practitioner's point of view have mainly been carried out in private practice, and at least 2 years ago. Few studies have looked at the patient's point of view. To date, no studies have been carried out in France on the patient's point of view. This is why the aim of our study is to: current state of smoking cessation in a hospital services: knowledge, attitudes and practices, from the point of view of the practitioner and the patient. Evaluation via a questionnaire.

Medical subject headings
Tobacco Use Cessation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT07031024
Study groupRoleWhat they receive
PatientsSurvey on smokers , feelings and perception of tabacco cessation , delivery by a dentist
Hospital practitionerSurvey on hospital dentists, knowledge, attitude, and practice

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Description of the participant's group

    Participant's questionnaire: 16 questions without score

    Measured: At the inclusion

Secondary outcomes (4)
  1. Identify the factors that influence responses to questions (Demographic characteristics)

    Demographic characteristics of participants: gender and age.

    Measured: At the inclusion

  2. Identify the factors that influence responses to questions (the knowledge particiapnts)

    Questionnaire:the knowledge participants without score

    Measured: At the inclusion

  3. Identify the factors that influence responses to questions (patients prejudices)

    Questionnaire:the patients prejudices without score

    Measured: At the inclusion

  4. Identify the factors that influence responses to questions ( Practionner status)

    Questionnaire: Professionnal status of practionners without score

    Measured: At the inclusion

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Jun 2025
  2. Study start1 Jul 2024
  3. Primary completion30 Aug 2025
  4. Study completion30 Aug 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Cross-sectional
Enrolment
400 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07031024
Sponsor's protocol ID
25Odonto01
Status last verified
Sep 2026
First submitted
21 Mar 2025
Last updated
22 Sep 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Tobacco Use Cessation, run by Centre Hospitalier Universitaire de Nice at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 12 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 22 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Description of the participant's group (time frame: At the inclusion). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Sep 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in